News Center

Home page

Peak Report

News reports

Jinhua Development Conference and Wucheng Development Conference

Release time:

2023-05-11

News from our newspaper On April 30 and May 1, the 3rd Jinhua Development Conference and the 2nd Wucheng Development Conference opened successively. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, won two major awards at the "Jinhua Development Outstanding Achievement Award" and "Wucheng Development Merit Award" at the two conferences, and participated in the Jinhua Life and Health Industry Summit roundtable and other activities.

The third Jinhua Development Conference takes "New Era, New Jinhua, New Development" as the theme. The vast number of local sages at home and abroad and people from all walks of life who care about and support the development of Jinhua gathered together to participate in the grand event. Since the reform and opening up, many outstanding Jinhua talents and "new Jinhua people" have made great contributions to Jinhua's economic and social development while starting and innovating. This conference has awarded a series of honorary awards such as "model figures", "outstanding achievements" and "outstanding contributions. Jiang Xiaomeng and other 10 entrepreneurs won the "Jinhua Development Outstanding Achievement Award", and Xing Zhihong, deputy secretary of the Jinhua Municipal Party Committee and Mayor, presented awards to them. During the

Jinhua Development Conference, a series of activities such as investment signing and industry forum were also held. Jiang Xiaomeng participated in the Jinhua Life and Health Industry Summit Roundtable to discuss the future development of the health industry with relevant experts and entrepreneurs. In recent years, great changes have taken place in the pharmaceutical industry, especially policy adjustments such as drug review and approval reform and centralized procurement, which have brought challenges to the strategic direction and operation mode of pharmaceutical enterprises. In response to the topic of "how enterprises should respond to major changes in the current pharmaceutical industry", Jiang Xiaomeng put forward the view of "conforming to the trend and constantly adjusting the dynamic adjustment of enterprise strategy and operation mode to adapt to the continuous changes in the market", and emphasized "innovation" in his speech ". He proposed that as a pharmaceutical company, it should increase innovation from the "three-pronged approach" of R & D, manufacturing, and sales. On the R & D side, we should continue to increase investment in R & D. On the one hand, we should devote ourselves to the research and development of innovative drugs and improved new drugs with clinical value oriented and completely independent intellectual property rights. On the other hand, we should actively develop differentiated varieties such as pediatric drugs, rare disease drugs and characteristic traditional Chinese medicine encouraged by the state. On the manufacturing side, production enterprises should "deeply understand" the whole industrial chain, realize the whole chain control of production costs from raw materials, intermediates to preparations, and constantly improve the digital intelligence level of enterprises, improve labor productivity, and reduce the cost in the production and manufacturing process, so as to gain competitive advantage in the extreme competitive environment and seize the opportunity in centralized procurement. On the sales side, enterprises should not only aim at the domestic market, but also actively "go out to sea", build an international marketing team, and strive to open up the high-end markets in Europe, America and Japan and the "Belt and Road Initiative" market in Southeast Asia and Africa.

5# The second Wucheng Development Conference, which opened on September 1, took "New Journey, New Opportunity, New Wucheng" as the theme. The children of Wucheng at home and abroad gathered together to talk about Sangzi, narrate the feelings of the countryside, and seek the future together. The conference awarded a series of awards to those who have made outstanding contributions to the development of Wucheng. Jiang Xiaomeng and other 10 well-known entrepreneurs in Wucheng won the "Wucheng Development Merit Award".

"'Jinhua Development Outstanding Achievement Award' and' Wucheng Development Merit Award' are two very important awards, but this honor should belong to all peak people." In an interview with our reporter, Chairman Jiang Xiaomeng emphasized, "The reason why I can win these two awards is because of the healthy development of the peak in recent years, and the contribution to the social and economic development of Jinhua and Wucheng. The city and Wucheng district party committees, government departments, and all sectors of society have affirmed, and the current good development of the peak is the result of the joint efforts of the group's management teams at all levels and all employees. At present, we are facing an unprecedentedly complex market environment. We have to meet many difficulties and challenges. As a peak person, we should unite and redouble our efforts, continue to work hard and forge ahead, and repay the high hopes of Jinhua and Wucheng folks with better business performance." (Reporter)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页